Health

North Carolina Governor Roy Cooper’s administration has received approval from the Centers for Medicare & Medicaid Services (CMS) for a groundbreaking proposal aimed at hospitals in the state. The proposal offers hospitals a financial incentive to eliminate patients’ medical debt and implement policies to prevent future liabilities. This initiative, described as a first-of-its-kind in the
0 Comments
When considering the spread of the dengue virus, it becomes evident that the world is facing a significant challenge. The most common mosquito-borne virus has become the poster child for the explosion of epidemic, vector-borne diseases in the 21st century. According to recent statistics from the CDC, the number of reported cases of dengue has
0 Comments
As the world becomes increasingly interconnected through social media, healthcare professionals are leveraging these platforms to advocate for important issues. Cardiothoracic ICU nurse Alexis Smith, also known as Miss Kansas 2024, went viral for her advocacy for healthy relationships. She courageously called out her alleged abuser on the pageant stage, shedding light on the importance
0 Comments
As the world was shaken by a software update glitch causing chaos in computer systems, the healthcare sector also felt the impact. The overreliance on technology in healthcare was put to the test as institutions had to resort to manual procedures due to system outages. This incident raised critical questions about the extent to which
0 Comments
With the rise of artificial intelligence (AI) solutions in healthcare, there is a growing concern about whether AI will eventually replace human doctors. While AI shows promise in areas such as diagnostic accuracy and information processing, it faces significant barriers when it comes to trust, human interaction, and oversight. As a result, it is crucial
0 Comments
A recent analysis of a large commercial database has suggested that sodium glucose co-transporter 2 (SGLT2) inhibitors, such as empagliflozin (Jardiance) and dapagliflozin (Farxiga), may provide more protection against diabetic retinopathy compared to other hypoglycemic agents. The study indicated that SGLT2 inhibitors reduced the risk of sight-threatening retinopathy by 21-39% when compared to GLP-1 receptor
0 Comments